BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 29560824)

  • 1. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
    Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
    NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
    Sharma A; Rani R
    J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
    Zhang T; Zhang L; Payne PRO; Li F
    Methods Mol Biol; 2021; 2194():223-238. PubMed ID: 32926369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Propagation Predicts Drug Synergy in Cancers.
    Li H; Li T; Quang D; Guan Y
    Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
    Malyutina A; Majumder MM; Wang W; Pessia A; Heckman CA; Tang J
    PLoS Comput Biol; 2019 May; 15(5):e1006752. PubMed ID: 31107860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge.
    Ding P; Yin R; Luo J; Kwoh CK
    IEEE J Biomed Health Inform; 2019 May; 23(3):1336-1345. PubMed ID: 29994408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
    Liu Q; Xie L
    PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNSynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations.
    Huangfu X; Zhang C; Li H; Li S; Li Y
    Comput Biol Chem; 2024 Jun; 110():108054. PubMed ID: 38522389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data.
    Celebi R; Bear Don't Walk O; Movva R; Alpsoy S; Dumontier M
    Sci Rep; 2019 Jun; 9(1):8949. PubMed ID: 31222109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple gene set-based method accurately predicts the synergy of drug pairs.
    Hsu YC; Chiu YC; Chen Y; Hsiao TH; Chuang EY
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):66. PubMed ID: 27585722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
    Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
    Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning.
    Preuer K; Lewis RPI; Hochreiter S; Bender A; Bulusu KC; Klambauer G
    Bioinformatics; 2018 May; 34(9):1538-1546. PubMed ID: 29253077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to predicting the synergy of anti-cancer drug combinations using document-based feature extraction.
    Shim Y; Lee M; Kim PJ; Kim HG
    BMC Bioinformatics; 2022 May; 23(1):163. PubMed ID: 35513784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DTF: Deep Tensor Factorization for predicting anticancer drug synergy.
    Sun Z; Huang S; Jiang P; Hu P
    Bioinformatics; 2020 Aug; 36(16):4483-4489. PubMed ID: 32369563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
    Berlow NE; Rikhi R; Geltzeiler M; Abraham J; Svalina MN; Davis LE; Wise E; Mancini M; Noujaim J; Mansoor A; Quist MJ; Matlock KL; Goros MW; Hernandez BS; Doung YC; Thway K; Tsukahara T; Nishio J; Huang ET; Airhart S; Bult CJ; Gandour-Edwards R; Maki RG; Jones RL; Michalek JE; Milovancev M; Ghosh S; Pal R; Keller C
    BMC Cancer; 2019 Jun; 19(1):593. PubMed ID: 31208434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy.
    Liu H; Zhang W; Zou B; Wang J; Deng Y; Deng L
    Nucleic Acids Res; 2020 Jan; 48(D1):D871-D881. PubMed ID: 31665429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RECOVER identifies synergistic drug combinations in vitro through sequential model optimization.
    Bertin P; Rector-Brooks J; Sharma D; Gaudelet T; Anighoro A; Gross T; Martínez-Peña F; Tang EL; Suraj MS; Regep C; Hayter JBR; Korablyov M; Valiante N; van der Sloot A; Tyers M; Roberts CES; Bronstein MM; Lairson LL; Taylor-King JP; Bengio Y
    Cell Rep Methods; 2023 Oct; 3(10):100599. PubMed ID: 37797618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An In Silico Method for Predicting Drug Synergy Based on Multitask Learning.
    Chen X; Luo L; Shen C; Ding P; Luo J
    Interdiscip Sci; 2021 Jun; 13(2):299-311. PubMed ID: 33611781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting drug synergy for precision medicine using network biology and machine learning.
    Cuvitoglu A; Zhou JX; Huang S; Isik Z
    J Bioinform Comput Biol; 2019 Apr; 17(2):1950012. PubMed ID: 31057072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.